Browse > Article

A Study for Direct Application of Drug on Oral Mucosa  

Jeong, Sung-Hee (Department of Oral Medicine, School of Dentistry, Pusan National University)
Ok, Soo-Min (Department of Oral Medicine, School of Dentistry, Pusan National University)
Huh, Joon-Young (Department of Oral Medicine, School of Dentistry, Pusan National University)
Ko, Myung-Yun (Department of Oral Medicine, School of Dentistry, Pusan National University)
Ahn, Yong-Woo (Department of Oral Medicine, School of Dentistry, Pusan National University)
Publication Information
Journal of Oral Medicine and Pain / v.35, no.4, 2010 , pp. 229-235 More about this Journal
Abstract
A common method for treating oral mucosal diseases is taking medication by oral administration. The oral administration is the method of least resistance. Because large part of drugs is degraded by liver, it is necessary to take more drugs getting to appropriate level in blood stream. And there are so many side effects when patients take drugs by oral administration. In so many cases, the patients who suffer from oral mucosal problems have the other general diseases simultaneously. Willingly or not, some patients can't take the medicine by oral administration. Number of topical drugs for oral mucosal disease is less than that for skin diseases because the environment of oral mucosa prevents activity of medicine. In this paper, research on effects of topical type medication for treating oral mucosal diseases is conducted through investigating currently used medications and their effects. In addition, effects of dissolved oral medications with appropriate solvent are demonstrated if this medication is useful for patients clinically.
Keywords
Oral mucosa; Drug; Topical application; Transdermal drug delivery system;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: A review. Recent Pat Drug Deliv Formul 2009;3:162-173.   DOI   ScienceOn
2 Motlekar NA, Youan BB. The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins. J Control Release 2006;113:91-101.   DOI   ScienceOn
3 Gonzalez-Mariscal L, Hernandez S, Vega J. Inventions designed to enhance drug delivery across epithelial and endothelial cells through the paracellular pathway. Recent Pat Drug Deliv Formul 2008;2:145-176.   DOI   ScienceOn
4 Audet MC, Moreau M, Koltun WD et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: A randomized controlled trial. JAMA 2001;285:2347-2354.   DOI   ScienceOn
5 Nangia A. Science and technology of bioadhesivebased targeted oral delivery systems. Pharm Technol 2008;32:100-121.
6 Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S. Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies. J Control Release 2004;98:269-279.   DOI   ScienceOn
7 Naik A, Kalia YN, Guy RH. Transdermal drug delivery: Overcoming the skin's barrier function. Pharm Sci Technolo Today 2000;3:318-326.   DOI   ScienceOn
8 Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 1994;13:43-74.   DOI   ScienceOn
9 Squier CA. The permeability of oral mucosa. Crit Rev Oral Biol Med 1991;2:13-32.   DOI
10 Wertz PW, Squier CA. Cellular and molecular basis of barrier function in oral epithelium. Crit Rev Ther Drug Carrier Syst 1991;8:237-269.
11 심영주, 최종훈, 안형준, 권정승. 구강작열감 증후군에서 클로나제팜의 국소적 적용. 대한구강내과학회지 2009; 34:429-433.   과학기술학회마을
12 Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release 2000;66:127-133.   DOI   ScienceOn
13 Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1999;88:948.
14 Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999; 184:1-6.   DOI   ScienceOn
15 Tennstedt D, Lachapelle J. Allergic contact dermatitis from colophony in a nitroglycerin transdermal therapeutic system. Contact Derm 1990;23:254-255.
16 Madhav NV, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: A review. J Control Release 2009;140:2-11.   DOI   ScienceOn
17 Bertam G., Katzung. Katzung's Basic & Clinical Pharmacology, 2002, 대한의학서적, pp. 1-34.
18 Shiboski CH, Hodgson TA, Ship JA, Schiodt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S66.e1-19.   DOI
19 Gremeau-Richard C, Woda A, Navez ML et al. Topical clonazepam in stomatodynia: A randomised placebo-controlled study. Pain 2004;108:51-57.   DOI   ScienceOn
20 Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: Clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002;41:661-680.   DOI   ScienceOn
21 Slomiany BL, Murty VL, Piotrowski J, Slomiany A. Salivary mucins in oral mucosal defense. Gen Pharmacol 1996;27:761-771.   DOI   ScienceOn
22 Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992;81: 1-10.   DOI
23 Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994;13:1-22.   DOI   ScienceOn
24 Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 1994;13:43-74.   DOI   ScienceOn
25 Squier CA, Kremer MJ, Bruskin A, Rose A, Haley JD. Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro. Pharm Res 1999;16:1557-1563.   DOI   ScienceOn
26 Ganem-Quintanar A, Falson-Rieg F, Buri P. Contribution of lipid components to the permeability barrier of oral mucosa. Eur J Pharm Biopharm 1997;44:107-120.   DOI   ScienceOn
27 Shojaei AH. Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci 1998; 1:15-30.
28 Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A 1993;90:10504-10508.   DOI   ScienceOn
29 Kligman AM. Skin permeability: Dermatologic aspects of transdermal drug delivery. Am Heart J 1984;108:200-206.   DOI   ScienceOn
30 Lee J, Lee SK, Choi YW. The effect of storage conditions on the permeability of porcine buccal mucosa. Arch Pharm Res 2002;25:546-549.   과학기술학회마을   DOI   ScienceOn
31 Torres V, Lopes JC, Silva M, Soares AP. Transdermal contact dermatitis from nitroglycerin. Contact Derm 1990;23:265-265.
32 Guy RH. Current status and future prospects of transdermal drug delivery. Pharm Res 1996;13:1765-1769.   DOI   ScienceOn
33 오승열. 경피약물전달. 한국피부장벽학회지 2006;8:76-82.